YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Morgan Frank Chief Financial Officer - Peter Sorensen Full Conference Call Transcript Operator: Hello and wel…
Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Morgan FrankChief Financial Officer - Peter Sorensen TAKEAWAYS Revenue -- $9.7 million, a 3% decrease from $1…
Key Points Interested in Sanuwave Health Inc.? Here are five stocks we like better. Second-quarter revenue fell 3% year over year to $9.7 million, as a 34% decline in UltraMIST system sales offset continued growth in recurring applicator r…
Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025. GAAP Operating (Loss) Income was $(0.3) million for Q2 2026 versus $1.4 million in Q2 2025. EDEN PRAIRIE, M…
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday,…
(RTTNews) - Sanuwave Health, Inc. (SNWV) provided a preliminary revenue update for the second quarter of 2026, reflecting a year-over-year revenue decline. However, the expected revenue exceeds the company's revised guidance issued on June…
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenues…
(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE…
Sanuwave Health's (SNWV) Q2 revenue is expected to be in the range of $8.5 million to $9.5 million, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Image source: The Motley Fool. DATE Wednesday, May 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Morgan Frank Chief Financial Officer — Peter Sorensen Full Conference Call Transcript Let's dig into what was a good, s…
Image source: The Motley Fool. DATE Wednesday, May 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Morgan Frank Chief Financial Officer — Peter Stegagno Full Conference Call Transcript Okay. So as we mentioned in our p…
SANUWAVE Health Inc (OTC:SNWV) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire ca…
SANUWAVE Health, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 p…
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday…
Wall Street expects a year-over-year increase in earnings on higher revenues when Sanuwave Health Inc. (SNWV) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's…
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management’s Multi-Strategy Composite posted a -23.…
[Wall street and Broadway road sign in New York City] Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. SUNDA…
Earnings Call Insights: SANUWAVE Health, Inc. (SNWV) Q4 2025 MANAGEMENT VIEW * CEO Morgan Frank reported "Q4 was an all-time record for SANUWAVE with revenues of $13.4 million, up 30% versus the same quarter last year and adjusted EBITDA o…
Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were $44.1 million up 35.0% from full year 2024 revenues. This was an all-time annual record for the…
The following companies are expected to report earnings prior to market open on 03/27/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Carnival Corporation (CCL)is reporting for the quarter ending February 2…
EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday,…
Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. Deep Sail Capital Partners returned 14.2% net of fees in Q4 2025, with an average long exposure o…
Sanuwave is pleased to announce preliminary revenues of $13.3 million to $13.4 million for the fourth quarter ended December 31, 2025. This represents the highest quarterly revenues in Company history. Q4 2025 revenue increased between 29%…
As the U.S. stock market rebounds with major indexes like the Dow Jones and S&P 500 poised to break losing streaks thanks to cooler-than-expected inflation data, investor sentiment is cautiously optimistic. In such a climate, growth stocks…
EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved next-generation wound care products, is pleased to announce that it will be atten…
Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Sanuwave He…
* SANUWAVE Health press release [https://seekingalpha.com/pr/20298556-sanuwave-announces-q3-fy2025-financial-results] (SNWV [https://seekingalpha.com/symbol/SNWV]): Q3 GAAP EPS of $0.46 beats by $0.14. * Revenue of $11.5M beats by $0.07M.…
Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024. GAAP Operating Income was $1.5 million fo…
Insulet (PODD) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $0.9 per share a year ago. These figures are adjusted for non-recurring items. This q…
MariMed Inc. (MRMD) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items. A quarter ago,…
CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 97610 2026 rates for physician offices, home visits, long-term care, and hospitals are in line with the proposed rule and remain materially uncha…
Health care stocks edged lower late Tuesday afternoon, with the NYSE Health Care Index and the Healt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Stock futures dipped in early trading on Tuesday as investors turned cautious due to concerns over the ongoing U.S. government shutdown. The political uncertainty has been compounded by delayed economic data releases, which is leading to m…
* Sanuwave Health (NASDAQ:SNWV [https://seekingalpha.com/symbol/SNWV]) announced on Monday that its revenues for the third quarter of 2025 are expected to be in the range of $11.4 to $11.6 million versus consensus of $12.37 million [https:…
Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025 revenue increased between 22% and 24% vs Q…
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan C…